Michael Nehls, MD, PhDDec 19 · Michael’s Substack

In this article, Jon Fleetwood once again shows how the military-industrial complex, under the guise of “pandemic preparedness,” creates and stages pandemics in a completely artificial way—right down to the virus itself. He provides further evidence that the pandemic was planned well in advance and that dangerous viruses such as SARS-CoV-2 could have been (and will continue to be!) created in any laboratory using purely synthetic methods. A global ban on this gain-of-function research is vital for the survival of humanity! Fleetwood’s article and conclusions should be required reading.

DARPA’s Secret 60-Day Pandemic Pipeline: FOIA Documents Reveal U.S. Military Program to Synthesize Viruses From Digital Sequences and Mass-Produce mRNA Countermeasures

Newly released DARPA files show a Pentagon-backed system designed to turn raw genetic code into real viruses, isolate antibodies, and manufacture 20,000 doses of mRNA vaccines in just two months.

Jon Fleetwood Dec 19

READ IN APP

This report examines an October 2025 FOIA release from U.S. Right to Know regarding DARPA’s “Pandemic Prevention Platform (P3)” Research Description Document (RDD) from Duke University, Revision 3 (January 2020)—a program that was already operational before the COVID-19 pandemic began.

DARPA’s own words paint the clearest picture yet of a fully integrated pre-COVID pandemic U.S. military system that can:

• take only a digital sequence of a virus
• synthesize an infectious clone
• grow it in a “Thaw-and-Infect” panel of human and animal cell lines
• isolate antibodies from infected blood
• evolve those antibodies using computational mutation engines
• encode those antibodies into modified mRNA
• package them in lipid nanoparticles
• and produce 20,000 doses within 60 days

The program is open about building a platform that works even when no physical virus exists, only a computer file.

Share

Share Jon Fleetwood

• Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
• If you value this reporting, consider upgrading to a paid subscription.